Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: RepliVax Vaccine Platform |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-11-04 |
| Study Made Public: | 2016-03-10 |
Title
DC Targeting Selection Study (AUP567)
Description
CAVD 434 (AUP 567) is a non-human primate study comparing NYVAC/protein-adjuvant prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
Poly ICLC NYVAC-KC-gp140(ZM96) NYVAC-KC-Gag(ZM96)Pol-Nef(CN54) αCD40-gp140Z αLOX-1-gp140ZIntegrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.